<s id="wsj_0992.1"> 22
5 	 0 	 (S/S)/NP 	 2 	 article Regarding
5 	 1 	 NP[nb]/N 	 1 	 article your
5 	 2 	 N/N 	 1 	 article Oct.
5 	 3 	 N/N 	 1 	 article 4
5 	 4 	 N/N 	 1 	 article page-one
5 	 7 	 NP\NP 	 1 	 article Blood
5 	 8 	 (NP\NP)/NP 	 1 	 article on
7 	 6 	 (NP\NP)/(NP\NP) 	 2 	 Blood Bad
11 	 8 	 (NP\NP)/NP 	 2 	 battle on
11 	 9 	 NP[nb]/N 	 1 	 battle the
11 	 10 	 N/N 	 1 	 battle generic-drug
15 	 13 	 NP[nb]/N 	 1 	 Institute The
15 	 14 	 N/N 	 1 	 Institute Epilepsy
15 	 16 	 (S[dcl]\NP)/NP 	 1 	 Institute is
16 	 0 	 (S/S)/NP 	 1 	 is Regarding
16 	 17 	 (S\NP)\(S\NP) 	 2 	 is not
21 	 16 	 (S[dcl]\NP)/NP 	 2 	 organization is
21 	 18 	 NP/NP 	 1 	 organization just
21 	 19 	 NP[nb]/N 	 1 	 organization a
21 	 20 	 N/N 	 1 	 organization patient-advocacy
<\s>
<s id="wsj_0992.2"> 18
0 	 1 	 (S[dcl]\NP)/NP 	 1 	 It is
1 	 2 	 (S\NP)\(S\NP) 	 2 	 is primarily
7 	 1 	 (S[dcl]\NP)/NP 	 2 	 facility is
7 	 3 	 NP[nb]/N 	 1 	 facility a
7 	 4 	 N/N 	 1 	 facility certified
7 	 5 	 N/N 	 1 	 facility outpatient
7 	 6 	 N/N 	 1 	 facility treatment
7 	 8 	 ((S[ng]\NP)/PP)/NP 	 1 	 facility providing <XB>
10 	 8 	 ((S[ng]\NP)/PP)/NP 	 3 	 services providing
10 	 9 	 N/N 	 1 	 services comprehensive
11 	 8 	 ((S[ng]\NP)/PP)/NP 	 2 	 to providing
12 	 11 	 PP/NP 	 1 	 people to
12 	 13 	 (NP\NP)/NP 	 1 	 people with
14 	 13 	 (NP\NP)/NP 	 2 	 epilepsy with
17 	 11 	 PP/NP 	 1 	 families to
17 	 16 	 NP[nb]/N 	 1 	 families their
<\s>
<s id="wsj_0992.3"> 17
1 	 0 	 NP[nb]/N 	 1 	 institute The
1 	 2 	 (NP[nb]/N)\NP 	 2 	 institute 's
4 	 2 	 (NP[nb]/N)\NP 	 1 	 efforts 's
4 	 3 	 N/N 	 1 	 efforts advocacy
4 	 5 	 (S[dcl]\NP)/(S[pss]\NP) 	 1 	 efforts are
4 	 6 	 (S[pss]\NP)/PP 	 1 	 efforts based <XB>
6 	 5 	 (S[dcl]\NP)/(S[pss]\NP) 	 2 	 based are
7 	 6 	 (S[pss]\NP)/PP 	 2 	 on based
9 	 7 	 PP/NP 	 1 	 needs on
9 	 8 	 NP[nb]/N 	 1 	 needs the
9 	 10 	 (NP\NP)/NP 	 1 	 needs of
12 	 10 	 (NP\NP)/NP 	 2 	 population of
12 	 11 	 NP[nb]/N 	 1 	 population the
12 	 14 	 (S[dcl]\NP)/NP 	 2 	 population serves <XU>
12 	 16 	 (S[dcl]\NP)/NP 	 2 	 population represents <XU>
13 	 14 	 (S[dcl]\NP)/NP 	 1 	 it serves
13 	 16 	 (S[dcl]\NP)/NP 	 1 	 it represents <XU>
<\s>
<s id="wsj_0992.4"> 19
1 	 0 	 (S/S)/NP 	 2 	 1985 In
5 	 3 	 NP[nb]/N 	 1 	 Tribune the
5 	 4 	 N/N 	 1 	 Tribune Medical
5 	 6 	 (S[dcl]\NP)/S[em] 	 1 	 Tribune reported
6 	 0 	 (S/S)/NP 	 1 	 reported In
7 	 6 	 (S[dcl]\NP)/S[em] 	 2 	 that reported
10 	 8 	 NP[nb]/N 	 1 	 number a
10 	 9 	 N/N 	 1 	 number growing
10 	 11 	 (NP\NP)/NP 	 1 	 number of
10 	 13 	 (S[dcl]\NP)/(S[ng]\NP) 	 1 	 number are
10 	 14 	 (S[ng]\NP)/NP 	 1 	 number challenging <XB>
12 	 11 	 (NP\NP)/NP 	 2 	 critics of
13 	 7 	 S[em]/S[dcl] 	 1 	 are that
14 	 13 	 (S[dcl]\NP)/(S[ng]\NP) 	 2 	 challenging are
18 	 14 	 (S[ng]\NP)/NP 	 2 	 equation challenging
18 	 15 	 NP[nb]/N 	 1 	 equation the
18 	 16 	 N/N 	 1 	 equation FDA
18 	 17 	 N/N 	 1 	 equation bioequivalence-therapeutic-equivalence
<\s>
<s id="wsj_0992.5"> 21
0 	 1 	 (S[dcl]\NP)/S[dcl] 	 1 	 They contend
1 	 20 	 (S[dcl]\S[dcl])\NP 	 1 	 contend said
2 	 3 	 (S[dcl]\NP)/(S[pss]\NP) 	 1 	 it is
2 	 4 	 (S[pss]\NP)/PP 	 1 	 it based <XB>
3 	 1 	 (S[dcl]\NP)/S[dcl] 	 2 	 is contend
4 	 3 	 (S[dcl]\NP)/(S[pss]\NP) 	 2 	 based is
5 	 4 	 (S[pss]\NP)/PP 	 2 	 on based
7 	 5 	 PP/NP 	 1 	 assumption on
7 	 6 	 NP[nb]/N 	 1 	 assumption an
7 	 8 	 (NP\NP)/(S[dcl]\NP) 	 1 	 assumption that
7 	 9 	 (S[dcl]\NP)/(S[pt]\NP) 	 1 	 assumption has <XB>
7 	 13 	 S[pss]\NP 	 1 	 assumption proven <XB>
9 	 8 	 (NP\NP)/(S[dcl]\NP) 	 2 	 has that
9 	 10 	 (S\NP)\(S\NP) 	 2 	 has not
9 	 11 	 (S\NP)\(S\NP) 	 2 	 has yet
12 	 9 	 (S[dcl]\NP)/(S[pt]\NP) 	 2 	 been has
13 	 12 	 (S[pt]\NP)/(S[pss]\NP) 	 2 	 proven been
13 	 14 	 ((S\NP)\(S\NP))/NP 	 2 	 proven in
16 	 14 	 ((S\NP)\(S\NP))/NP 	 3 	 tests in
16 	 15 	 N/N 	 1 	 tests valid
19 	 18 	 NP[nb]/N 	 1 	 Tribune the
19 	 20 	 (S[dcl]\S[dcl])\NP 	 2 	 Tribune said
<\s>
<s id="wsj_0992.6"> 34
1 	 0 	 (S/S)/NP 	 2 	 1986 In
5 	 3 	 NP[nb]/N 	 1 	 patients some
5 	 4 	 N/N 	 1 	 patients institute
5 	 6 	 (S[dcl]\NP)/(S[ng]\NP) 	 1 	 patients were
5 	 7 	 (S[ng]\NP)/NP 	 1 	 patients reporting <XB>
6 	 0 	 (S/S)/NP 	 1 	 were In
7 	 6 	 (S[dcl]\NP)/(S[ng]\NP) 	 2 	 reporting were
7 	 10 	 ((S\NP)\(S\NP))/S[dcl] 	 2 	 reporting when
9 	 7 	 (S[ng]\NP)/NP 	 2 	 seizures reporting
9 	 8 	 N/N 	 1 	 seizures breakthrough
11 	 12 	 (S[dcl]\NP)/(S[pss]\NP) 	 1 	 they were
11 	 13 	 ((S[pss]\NP)/PP)/PP 	 1 	 they switched <XB>
12 	 10 	 ((S\NP)\(S\NP))/S[dcl] 	 3 	 were when
13 	 12 	 (S[dcl]\NP)/(S[pss]\NP) 	 2 	 switched were
14 	 13 	 ((S[pss]\NP)/PP)/PP 	 3 	 from switched
18 	 14 	 PP/NP 	 1 	 medication from
18 	 15 	 NP[nb]/N 	 1 	 medication a
18 	 16 	 N/N 	 1 	 medication specific
18 	 17 	 N/N 	 1 	 medication brand-name
19 	 13 	 ((S[pss]\NP)/PP)/PP 	 2 	 to switched
22 	 19 	 PP/NP 	 1 	 one to
22 	 20 	 NP[nb]/N 	 1 	 one a
22 	 21 	 N/N 	 1 	 one generic
24 	 13 	 ((S[pss]\NP)/PP)/PP 	 3 	 from switched
27 	 24 	 PP/NP 	 1 	 manufacturer from
27 	 25 	 N/N 	 1 	 manufacturer one
27 	 26 	 N/N 	 1 	 manufacturer generic
27 	 28 	 (NP\NP)/NP 	 1 	 manufacturer of
31 	 28 	 (NP\NP)/NP 	 2 	 product of
31 	 29 	 NP[nb]/N 	 1 	 product a
31 	 30 	 N/N 	 1 	 product specific
32 	 13 	 ((S[pss]\NP)/PP)/PP 	 2 	 to switched
33 	 32 	 PP/NP 	 1 	 another to
<\s>
<s id="wsj_0992.7"> 12
1 	 0 	 (S/S)/NP 	 2 	 addition In
3 	 4 	 (S[dcl]\NP)/(S[ng]\NP) 	 1 	 neurologists were
3 	 5 	 (S[ng]\NP)/(S[to]\NP) 	 1 	 neurologists beginning <XB>
3 	 7 	 (S[b]\NP)/NP 	 1 	 neurologists report <XB>
4 	 0 	 (S/S)/NP 	 1 	 were In
5 	 4 	 (S[dcl]\NP)/(S[ng]\NP) 	 2 	 beginning were
6 	 5 	 (S[ng]\NP)/(S[to]\NP) 	 2 	 to beginning
7 	 6 	 (S[to]\NP)/(S[b]\NP) 	 2 	 report to
7 	 11 	 (S\NP)\(S\NP) 	 2 	 report well
9 	 7 	 (S[b]\NP)/NP 	 2 	 observations report
9 	 8 	 NP[nb]/N 	 1 	 observations these
11 	 10 	 ((S\NP)\(S\NP))/((S\NP)\(S\NP)) 	 3 	 well as
<\s>
<s id="wsj_0992.8"> 6
0 	 3 	 ((S\NP)\(S\NP))/S[dcl] 	 2 	 Call if
1 	 0 	 ((S[b]\NP)/(S[adj]\NP))/NP 	 3 	 it Call
1 	 2 	 S[adj]\NP 	 1 	 it anecdotal <XB>
2 	 0 	 ((S[b]\NP)/(S[adj]\NP))/NP 	 2 	 anecdotal Call
4 	 5 	 S[dcl]\NP 	 1 	 you will
5 	 3 	 ((S\NP)\(S\NP))/S[dcl] 	 3 	 will if
<\s>
<s id="wsj_0992.9"> 23
3 	 1 	 NP[nb]/N 	 1 	 physician no
3 	 2 	 N/N 	 1 	 physician ethical
3 	 4 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 physician would
3 	 5 	 (S[b]\NP)/NP 	 1 	 physician switch <XB>
3 	 20 	 (S[b]\NP)/NP 	 1 	 physician prove <XB>
4 	 0 	 S/S 	 1 	 would But
5 	 4 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 switch would
6 	 5 	 (S[b]\NP)/NP 	 2 	 patients switch
6 	 7 	 (NP\NP)/(S[dcl]\NP) 	 1 	 patients who
6 	 8 	 (S[dcl]\NP)/(S[ng]\NP) 	 1 	 patients were <XB>
6 	 9 	 S[ng]\NP 	 1 	 patients doing <XB>
8 	 7 	 (NP\NP)/(S[dcl]\NP) 	 2 	 were who
9 	 8 	 (S[dcl]\NP)/(S[ng]\NP) 	 2 	 doing were
9 	 10 	 (S\NP)\(S\NP) 	 2 	 doing well
9 	 11 	 ((S\NP)\(S\NP))/NP 	 2 	 doing on
14 	 11 	 ((S\NP)\(S\NP))/NP 	 3 	 medication on
14 	 12 	 NP[nb]/N 	 1 	 medication a
14 	 13 	 N/N 	 1 	 medication specific
14 	 15 	 (NP\NP)/NP 	 1 	 medication from
18 	 15 	 (NP\NP)/NP 	 2 	 manufacturer from
18 	 16 	 NP[nb]/N 	 1 	 manufacturer a
18 	 17 	 N/N 	 1 	 manufacturer specific
20 	 19 	 (S[to]\NP)/(S[b]\NP) 	 2 	 prove to
22 	 20 	 (S[b]\NP)/NP 	 2 	 point prove
22 	 21 	 NP[nb]/N 	 1 	 point a
<\s>
<s id="wsj_0992.10"> 10
0 	 1 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 We do
0 	 3 	 (S[b]\NP)/PP 	 1 	 We depend <XB>
1 	 2 	 (S\NP)\(S\NP) 	 2 	 do not
3 	 1 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 depend do
3 	 7 	 ((S\NP)\(S\NP))/NP 	 2 	 depend for
4 	 3 	 (S[b]\NP)/PP 	 2 	 on depend
6 	 4 	 PP/NP 	 1 	 companies on
6 	 5 	 N/N 	 1 	 companies pharmaceutical
9 	 7 	 ((S\NP)\(S\NP))/NP 	 3 	 support for
9 	 8 	 NP[nb]/N 	 1 	 support our
<\s>
<s id="wsj_0992.11"> 28
1 	 0 	 NP[nb]/N 	 1 	 institute The
1 	 2 	 (S[dcl]\NP)/NP 	 1 	 institute has
1 	 14 	 (S[dcl]\NP)/NP 	 1 	 institute collects <XU>
1 	 18 	 (S[dcl]\NP)/NP 	 1 	 institute receives <XU>
5 	 2 	 (S[dcl]\NP)/NP 	 2 	 contracts has
5 	 3 	 N/N 	 1 	 contracts governmental
5 	 4 	 N/N 	 1 	 contracts service
5 	 6 	 (NP\NP)/NP 	 1 	 contracts for
8 	 6 	 (NP\NP)/NP 	 2 	 provision for
8 	 7 	 NP[nb]/N 	 1 	 provision the
8 	 9 	 (NP\NP)/NP 	 1 	 provision of
12 	 9 	 (NP\NP)/NP 	 2 	 services of
12 	 10 	 N/N 	 1 	 services direct
12 	 11 	 N/N 	 1 	 services patient
16 	 14 	 (S[dcl]\NP)/NP 	 2 	 fees collects
16 	 15 	 N/N 	 1 	 fees patient
18 	 20 	 ((S\NP)\(S\NP))/NP 	 2 	 receives through
19 	 18 	 (S[dcl]\NP)/NP 	 2 	 money receives
21 	 20 	 ((S\NP)\(S\NP))/NP 	 3 	 contributions through
21 	 22 	 (NP\NP)/NP 	 1 	 contributions from
23 	 22 	 (NP\NP)/NP 	 2 	 individuals from
25 	 22 	 (NP\NP)/NP 	 2 	 foundations from
27 	 22 	 (NP\NP)/NP 	 2 	 bequests from
<\s>
<s id="wsj_0992.12"> 24
1 	 0 	 NP[nb]/N 	 1 	 funds The
1 	 2 	 (S[pss]\NP)/PP 	 1 	 funds received <XB>
1 	 6 	 (S[dcl]\NP)/(S[pss]\NP) 	 1 	 funds are
1 	 7 	 (S[pss]\NP)/(S[to]\NP) 	 1 	 funds used <XB>
1 	 9 	 (S[b]\NP)/NP 	 1 	 funds offset <XB>
3 	 2 	 (S[pss]\NP)/PP 	 2 	 from received
5 	 3 	 PP/NP 	 1 	 firms from
5 	 4 	 N/N 	 1 	 firms pharmaceutical
7 	 6 	 (S[dcl]\NP)/(S[pss]\NP) 	 2 	 used are
8 	 7 	 (S[pss]\NP)/(S[to]\NP) 	 2 	 to used
9 	 8 	 (S[to]\NP)/(S[b]\NP) 	 2 	 offset to
11 	 9 	 (S[b]\NP)/NP 	 2 	 symposiums offset
11 	 10 	 N/N 	 1 	 symposiums physician
15 	 14 	 NP[nb]/N 	 1 	 symposiums these
15 	 16 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 symposiums do
15 	 18 	 (S[b]\NP)/NP 	 1 	 symposiums stress <XB>
16 	 17 	 (S\NP)\(S\NP) 	 2 	 do not
18 	 16 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 stress do
21 	 18 	 (S[b]\NP)/NP 	 2 	 medication stress
21 	 19 	 NP[nb]/N 	 1 	 medication any
21 	 20 	 N/N 	 1 	 medication particular
23 	 18 	 (S[b]\NP)/NP 	 2 	 manufacturer stress
23 	 19 	 NP[nb]/N 	 1 	 manufacturer any
23 	 20 	 N/N 	 1 	 manufacturer particular
<\s>
<s id="wsj_0992.13"> 20
2 	 0 	 NP[nb]/N 	 1 	 Institute The
2 	 1 	 N/N 	 1 	 Institute Epilepsy
2 	 3 	 (NP[nb]/N)\NP 	 2 	 Institute 's
4 	 3 	 (NP[nb]/N)\NP 	 1 	 reporting 's
4 	 5 	 (NP\NP)/NP 	 1 	 reporting of
4 	 8 	 (S[dcl]\NP)/PP 	 1 	 reporting stemmed
7 	 5 	 (NP\NP)/NP 	 2 	 seizures of
7 	 6 	 N/N 	 1 	 seizures breakthrough
9 	 8 	 (S[dcl]\NP)/PP 	 2 	 from stemmed
10 	 9 	 PP/NP 	 1 	 concerns from
10 	 11 	 (NP\NP)/NP 	 1 	 concerns about
13 	 11 	 (NP\NP)/NP 	 2 	 people about
13 	 12 	 NP[nb]/N 	 1 	 people the
13 	 15 	 (S[dcl]\NP)/NP 	 2 	 people treat <XU>
13 	 18 	 PP/NP 	 1 	 people about <XU>
14 	 15 	 (S[dcl]\NP)/NP 	 1 	 we treat
14 	 17 	 (S[dcl]\NP)/PP 	 1 	 we care <XU>
15 	 19 	 (S\NP)\(S\NP) 	 2 	 treat daily
17 	 19 	 (S\NP)\(S\NP) 	 2 	 care daily
18 	 17 	 (S[dcl]\NP)/PP 	 2 	 about care
<\s>
<s id="wsj_0992.14"> 12
0 	 2 	 (S[dcl]\NP)/(S[pss]\NP) 	 1 	 This was
0 	 3 	 (S[pss]\NP)/PP 	 1 	 This perceived <XB>
2 	 1 	 (S\NP)/(S\NP) 	 2 	 was perhaps
3 	 2 	 (S[dcl]\NP)/(S[pss]\NP) 	 2 	 perceived was
4 	 3 	 (S[pss]\NP)/PP 	 2 	 as perceived
7 	 4 	 PP/NP 	 1 	 stance as
7 	 5 	 NP[nb]/N 	 1 	 stance a
7 	 6 	 N/N 	 1 	 stance bold
11 	 4 	 PP/NP 	 1 	 suspicious as
11 	 10 	 (S[adj]\NP)/(S[adj]\NP) 	 2 	 suspicious thus
<\s>
<s id="wsj_0992.15"> 21
1 	 0 	 (S\NP)/(S\NP) 	 2 	 let But
1 	 3 	 (S\NP)\(S\NP) 	 2 	 let not
2 	 1 	 ((S[b]\NP)/(S[b]\NP))/NP 	 3 	 us let
2 	 4 	 (S[b]\NP)/NP 	 1 	 us confuse <XB>
4 	 1 	 ((S[b]\NP)/(S[b]\NP))/NP 	 2 	 confuse let
5 	 4 	 (S[b]\NP)/NP 	 2 	 profits confuse
5 	 6 	 (NP\NP)/NP 	 1 	 profits of
5 	 9 	 (S[ng]\NP)/PP 	 1 	 profits masquerading <XB>
8 	 6 	 (NP\NP)/NP 	 2 	 business of
8 	 7 	 N/N 	 1 	 business big
10 	 9 	 (S[ng]\NP)/PP 	 2 	 as masquerading
11 	 10 	 PP/NP 	 1 	 concerns as
11 	 12 	 (NP\NP)/NP 	 1 	 concerns for
11 	 18 	 (NP\NP)/NP 	 1 	 concerns for <XU>
13 	 14 	 (NP[nb]/N)\NP 	 2 	 people 's
16 	 12 	 (NP\NP)/NP 	 2 	 care for
16 	 14 	 (NP[nb]/N)\NP 	 1 	 care 's
16 	 15 	 N/N 	 1 	 care health
20 	 18 	 (NP\NP)/NP 	 2 	 cost for
20 	 19 	 NP[nb]/N 	 1 	 cost the
<\s>
<s id="wsj_0992.16"> 5
0 	 1 	 (S[wq]/S[q])\((NP\NP)/NP) 	 2 	 For whom
2 	 1 	 (S[wq]/S[q])\((NP\NP)/NP) 	 1 	 is whom
4 	 2 	 S[q]/NP 	 1 	 saving is
4 	 3 	 NP[nb]/N 	 1 	 saving the
<\s>
<s id="wsj_0992.17"> 22
1 	 0 	 S/S 	 1 	 not Surely
2 	 1 	 S[frg]/PP 	 1 	 to not
3 	 2 	 PP/NP 	 1 	 people to
3 	 4 	 (NP\NP)/NP 	 1 	 people with
3 	 6 	 (NP\NP)/(S[dcl]\NP) 	 1 	 people who
3 	 7 	 (S[dcl]\NP)/PP 	 1 	 people depend <XB>
3 	 19 	 (S[b]\NP)/NP 	 1 	 people maintain <XB>
5 	 4 	 (NP\NP)/NP 	 2 	 epilepsy with
7 	 6 	 (NP\NP)/(S[dcl]\NP) 	 2 	 depend who
7 	 17 	 (S\NP)\(S\NP) 	 2 	 depend daily
8 	 7 	 (S[dcl]\NP)/PP 	 2 	 on depend
11 	 8 	 PP/NP 	 1 	 levels on
11 	 9 	 NP[nb]/N 	 1 	 levels the
11 	 10 	 N/N 	 1 	 levels same
11 	 12 	 (NP\NP)/NP 	 1 	 levels of
11 	 14 	 (NP\NP)/NP 	 1 	 levels in
13 	 12 	 (NP\NP)/NP 	 2 	 medication of
16 	 14 	 (NP\NP)/NP 	 2 	 bloodstream in
16 	 15 	 NP[nb]/N 	 1 	 bloodstream their
19 	 18 	 (S[to]\NP)/(S[b]\NP) 	 2 	 maintain to
21 	 19 	 (S[b]\NP)/NP 	 2 	 control maintain
21 	 20 	 N/N 	 1 	 control seizure
<\s>
<s id="wsj_0992.18"> 1
1 	 0 	 N/N 	 1 	 Berner Reina
<\s>
<s id="wsj_0992.19"> 1
1 	 0 	 N/N 	 1 	 Director Executive
<\s>
<s id="wsj_0992.20"> 2
2 	 0 	 N/N 	 1 	 Katz Arnold
2 	 1 	 N/N 	 1 	 Katz M.
<\s>
